Enzymes are biochemical molecules released from living cells that act as biocatalysts and are extremely selective in their mode of action. Enzymes that can be used for medical purposes in an isolated form or can be used in combination with other treatments or drugs are called therapeutic enzymes. Enzymes have been used for therapeutic purposes for nearly 40 years.
Enzymes have two important properties that allow them to be used as potent drugs or therapeutic enzymes. These properties include high affinity and specificity for the enzyme to bind to its substrate. This property forms the basis for target-directed applications of therapeutic enzymes. A second important property of enzymes is their ability to convert multiple substrate molecules into desired product molecules.
Get Free Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/16765
These properties have allowed manufacturers to create potent and highly specific drugs from enzymes. Therapeutic enzymes can be used as a replacement for metabolic deficiencies and in the treatment of diseases such as cancer , cardiovascular disease, pain and inflammatory disorders.
According to data from the American Cancer Society, 1,685,210 new cancers are expected to be diagnosed in the United States alone in 2016, and according to data from the World Health Organization, 17.7 million people worldwide died from cardiovascular disease in 2015, according to data from the World Health Organization. This data reveals the potential of the Cancer and Cardiovascular Therapeutics market. Therapeutic enzymes are important in the treatment of both diseases, so their use is expected to become more common in the forecast period.
The most important factor projected to drive the growth of the therapeutic enzymes market is the increasing cancer and cardiovascular disease cases worldwide. In addition, lifestyle changes cause increased stress levels, which in turn cause increased cases of pain disorders and consequently increased demand for therapeutic enzymes.
Another factor that could boost revenues in the therapeutic enzyme market is increased healthcare spending leading to the adoption of advanced enzymes such as immobilized enzymes for therapeutic purposes.
Factors that may limit the growth of therapeutic enzymes during the forecast period include the fact that not all tissues can be treated with therapeutic enzyme therapy. Additionally, therapeutic enzyme therapy is expensive and more affordable options are available in the market, which may limit the growth of the therapeutic enzyme market.
Request Table of Contents @ https://www.persistencemarketresearch.com/toc/16765
Therapeutic Enzymes Market: Segmentation
| by product type |
|
| based on application |
|
| By end-user |
|
The therapeutic enzymes market is a growing market and is expected to witness even higher growth during the forecast period. Factors such as increasing population aging worldwide and increasing awareness of therapeutic enzymes are responsible for propelling the growth of the therapeutic enzyme market.
Growing number of pharmaceutical manufacturers in Asia Pacific, Middle East & Africa region owing to growing demand for drugs is also responsible for revenue growth of therapeutic enzymes market during the forecast period.
The therapeutic enzymes market is in a growth phase and thus this market is not fully developed in Asia Pacific and emerging regions of Middle East & Africa, but the therapeutic enzymes market is expected to witness high growth during the forecast period due to several factors. North America therapeutic enzymes are the most developed market in terms of revenue, followed by Europe.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/16765
Major Players in Therapeutic Enzymes Market include Novozymes, Roche Holdings AG, Thermo Fischer Scientific, Codexis Inc. To maintain their market share in the therapeutic enzyme market, key players are following strategies such as acquisitions and increasing their portfolios.
About Us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States United
States Ph.D. – +1-646-568-7751
US-Canada Toll Free – +1 800-961-0353
Japan Office: 1-2-1 Kinshi Arca Central Building
14 / F Tokyo, 130-0013, Japan
Tel 1-888-863-3700
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com